Labs212sp. z o.o.

Manufacture of other food products not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-04-27
Share capital
100 000,00 PLN
Activity description

Labs212 is a company that manufactures dietary supplements, including products like Homocysteine Support, Adeno B-12, Methyl B-12, and various vitamin complexes aimed at supporting the immune and nervous systems. Their offerings also include natural ingredients such as Beta Glucan and L-Lysine with Zinc, as well as formulations for joint and digestive health. Each product is developed with certified raw materials and undergoes testing for quality assurance.

Registered address
ul. Henryka Sienkiewicza 85/87/8, 90-057 Łódź, Poland
Website
labs212.plWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-95100-26323-FVVSS-10

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 675.20kMedianUSD 266.29kAverageUSD 5.03m
Net profit
This companyUSD 4.29kMedianUSD 2.47kAverageUSD 348.58k
Operating costs
This companyUSD 660.89kMedianUSD 259.61kAverageUSD 4.45m
Assets
This companyUSD 269.67kMedianUSD 249.77kAverageUSD 3.86m

Bank accounts

Registered as a VAT taxpayer on 2021-06-02. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,803
De minimis aid (in accordance with Commission Regulation 2023/2831)
$106.7K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,411

European Funds

ProjectEU co-financing
Rozwój eksportu firmy LABS212.
$77,299

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Beata Rogalska — President of the Management Board
Jacek Saczuk — Management Board Member & Attorney-in-fact (sole)

Manner of representation

The following is authorized to make declarations of will on behalf of the company: A) in the case of a one-person management board – the sole member of the management board acting independently; B) in the case of a two-member management board – each member of the management board acting independently.

Ownership

OwnerSharesShare valueStake
Beata Rogalska (53)
1,400$18,908.7070%
Jacek Saczuk (60)
600$8,103.7330%

Beneficial owners

Person
Beata Rogalska (53)
Jacek Saczuk (60)

Competitors

Name
Lab88sp. z o.o.
Bionatursp. z o.o. + limited partnership
Suplement.Iosp. z o.o.
Animal Nutraceuticalssp. z o.o.
MOG NutritionP.S.A.
IOCsp. z o.o.
Pharmavenesp. z o.o.
Colostrum Polskasp. z o.o.
Zojo. The Gorgeousness Companysp. z o.o.
Amberpharmsp. z o.o.

Change history

DateEvent
2021-11-02Share capital change
2021-05-17Address change
2020-04-27Entered in the register

FAQ

Last updated: 2026-09-25